K-V Pharma, Hologic Eye $60M Deal To End Makena Feud
K-V Pharmaceutical Co. reached a major milestone in its Chapter 11 case Wednesday, asking a New York bankruptcy judge to approve a $60 million settlement with Hologic Inc. to end their...To view the full article, register now.
Already a subscriber? Click here to view full article